Log in to save to my catalogue

Acetazolamide Use in Severe Chronic Obstructive Pulmonary Disease. Pros and Cons

Acetazolamide Use in Severe Chronic Obstructive Pulmonary Disease. Pros and Cons

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1910799089

Acetazolamide Use in Severe Chronic Obstructive Pulmonary Disease. Pros and Cons

About this item

Full title

Acetazolamide Use in Severe Chronic Obstructive Pulmonary Disease. Pros and Cons

Publisher

United States: American Thoracic Society

Journal title

Annals of the American Thoracic Society, 2017-07, Vol.14 (7), p.1086-1093

Language

English

Formats

Publication information

Publisher

United States: American Thoracic Society

More information

Scope and Contents

Contents

Acetazolamide is a carbonic anhydrase (CA) inhibitor sometimes used as a respiratory stimulant for patients with chronic obstructive pulmonary disease (COPD) with the goal of improving oxygenation, reducing carbon dioxide retention, and aiding liberation from mechanical ventilation and/or attempting to correct a metabolic alkalosis. However, the ne...

Alternative Titles

Full title

Acetazolamide Use in Severe Chronic Obstructive Pulmonary Disease. Pros and Cons

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1910799089

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1910799089

Other Identifiers

ISSN

2329-6933

E-ISSN

2325-6621

DOI

10.1513/AnnalsATS.201701-016FR

How to access this item